 We studied the usefulness of Patients with BCR of PCa after radical surgery and/or radiotherapy with or without androgen-deprivation therapy were included in the study. From November 2015 to October 2017 , 314 PCa patients with BCR were evaluated. Their median age was 70 years ( range 44-92 years) and their median PSApet was 0.83 ng/ml ( range 0.003-80.0 ng/ml). We confirmed the value of